|
|
|
| Self-expanding metallic stent or transanal drainage tube in malignant large-bowel obstruction: an observational cohort study |
| WEI Jing-jing,LIU Lu-peng,ZHUANG Ze-hao, ZHUANG Ze-hao, ZHENG Jian-tao, ZHENG Jian-tao,CHEN Qun,DING Jian,PAN Yu-feng |
| Department of Endoscopy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China; 2Department of Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China |
|
|
|
|
Abstract Objective To compare the outcomes after SEMS or TDT placement in patients with malignant large-bowel obstruction (MLBO). Methods 48 patients with MLBO from the clinical unit accepted SEMS (n=26) or TDT (n=22) placement from 2012 to 2016 were collected. The outcomes evaluation, successful rates of placement, clinical outcomes after decompression, complications, the timing of resuming to EN, Karnofsky Performance Status (KPS) scoring and the following-up therapeutic options were included. Results Technical success were achieved in 100% patients in both groups. Clinical success rates were 96.2% (25/26) for SEMS and 95.5% (21/22) for TDT. There was no perforation found in any group, while 7.7% (2/26) in SEMS and 18.2% (4/22) in TDT group experiencing a complication of displacement (P=0.26). 2 IQR(0~2) days and 3 IQR(2~5) days should be taken to resume to EN in each group, respectively (P=0.001). KPS scores were significantly higher in patients with SEMS (75 IQR50~80) than in those with TDT (35 IQR30~50) (P=0.001). There were 30.8% (8/26) patients undergoing stenting as bridge to surgery, 7.7% (2/26) patients for chemotherapy only and 61.5% (16/26) for palliation and nutritional therapy in SEMS group, while 31.8% (7/22), 0 and 59.1% (13/22) in TDT group, respectively (P=0.36). The patients requiring stoma creation were 57.1% (4/7) in TDT group and 25.0% (2/8) in SEMS group, respectively, while postoperative anastomotic leakage was found only in TDT group (1/7). Conclusions Both SEMS and TDT placement could achieve a clinical relief for MLBO effectively. However, SEMS placement is associated with earlier EN and is more obvious postoperative quality-of-life benefits in MLBO.
|
|
|
|
|
|
| [1] |
CHENG Guo-wei， SUN Li， CHEN Ping， HE Xiang-ling， SU Dan， XI Heng-zhi， ZANG Ding-qi. Nasojejunal nutrition therapy improves the efficacy and decreased adverse reactions of radiotherapy for esophageal cancer patients[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 332-336. |
| [2] |
1，2GENG Bi-zhu, 1ZHENG Jin. Review of family nutrition support research during the intermission of chemotherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(3): 386-390. |
| [3] |
CHANG Ge-yun. Immune enteral nutrition on advanced gastrointestinal cancer patients undergoing apatinib[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 230-235. |
| [4] |
1XU Hui-jun, 2YANG Yang, 1HE Yi-fu. The impact of nutritional status and adverse effects in enteral nutrition support for chemotherapy patients with gastric esophageal cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(4): 411-414. |
| [5] |
1LI Dong-yong, 2SUN Yan-bo, 1QI Ying-hua, 1LI Jian-guang, 1WANG Bin, 1LI Zhi-jun, 2CEN Yun-yun, 2XU Peng-yuan. Effect of appetite condition reflex stimulation on tolerance of early enteral nutrition after colorectal-carcinoma surgery[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(4): 366-371. |
| [6] |
1,2YANG Dong, 1,3HU Wen, 4 LI Xiao-cong,4 YANG Yan-gang, 4 LIU Zheng, 4 YANG Wei, 4 ZHANG Lin. Effect of marine collagen oligopeptide on plasma protein and complications in postoperative patients with esophageal cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(4): 376-379. |
|
|
|
|
